✦ LIBER ✦

Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle

✍ Scribed by R. Wolters; L. Schwentner; A. Regierer; M. Wischnewsky; R. Kreienberg; A. Wöckel

Book ID: 106379509
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 379 KB
Volume: 131
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-011-1874-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised study comparing primary end

A randomised study comparing primary endocrine therapy with primary chemo-endocrine therapy given at the time of relapse in patients with breast cancer

✍ Arvidson, Maria; Fjällskog, Marie-Louise; Hansen, Jörgen; Lundberg, Tore; Bergh, 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Incidence of contralateral breast cancer

Incidence of contralateral breast cancer in Japanese patients with unilateral minimum-risk primary breast cancer, and the benefits of endocrine therapy and radiotherapy

✍ Tomohiko Aihara, Shiro Tanaka, Yasuaki Sagara, Hiroji Iwata, Yasuo Hozumi… 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 286 KB

Epidermal growth factor receptor (EGFr)

Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer

✍ Nicholson, S; Halcrow, P; Sainsbury, JRC; Angus, B; Chambers, P; Farndon, JR; Ha 📂 Article 📅 1988 🏛 Nature Publishing Group 🌐 English ⚖ 940 KB

Phase 2 randomized trial of primary endo

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer

✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/

Impact of Body Mass Index on the Efficac

Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial

✍ Sestak, I. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

PCN97 TREATMENT OF PATIENTS WITH METASTA

PCN97 TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER (MBC) IN THE UKWHO PROGRESS ON TRASTUZUMAB AND HAVE PREVIOUSLY RECEIVED AN ANTHRACYCLINE AND ATAXANE: A NEED FOR EVIDENCE BASED THERAPIES?

✍ M Walker; J Unwin; C Relf; D Browning; M Amonkar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB